ATE240397T1 - Thiolprotease enthaltender impfstoff - Google Patents

Thiolprotease enthaltender impfstoff

Info

Publication number
ATE240397T1
ATE240397T1 AT93923592T AT93923592T ATE240397T1 AT E240397 T1 ATE240397 T1 AT E240397T1 AT 93923592 T AT93923592 T AT 93923592T AT 93923592 T AT93923592 T AT 93923592T AT E240397 T1 ATE240397 T1 AT E240397T1
Authority
AT
Austria
Prior art keywords
vaccine containing
containing thiol
thiol protease
protease
fluke
Prior art date
Application number
AT93923592T
Other languages
English (en)
Inventor
John Pius Dalton
Stuart Andrews
Original Assignee
John Pius Dalton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929222156A external-priority patent/GB9222156D0/en
Application filed by John Pius Dalton filed Critical John Pius Dalton
Application granted granted Critical
Publication of ATE240397T1 publication Critical patent/ATE240397T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
AT93923592T 1992-10-21 1993-10-21 Thiolprotease enthaltender impfstoff ATE240397T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929222156A GB9222156D0 (en) 1992-10-21 1992-10-21 Vaccine
GB939307028A GB9307028D0 (en) 1992-10-21 1993-04-02 Vaccine
PCT/GB1993/002172 WO1994009142A1 (en) 1992-10-21 1993-10-21 Vaccine containing a thiol protease

Publications (1)

Publication Number Publication Date
ATE240397T1 true ATE240397T1 (de) 2003-05-15

Family

ID=26301834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93923592T ATE240397T1 (de) 1992-10-21 1993-10-21 Thiolprotease enthaltender impfstoff

Country Status (12)

Country Link
US (2) US6623735B1 (de)
EP (1) EP0666919B1 (de)
JP (1) JPH08502404A (de)
AT (1) ATE240397T1 (de)
AU (1) AU5340094A (de)
CA (1) CA2147378A1 (de)
DE (1) DE69332977T2 (de)
DK (1) DK0666919T3 (de)
ES (1) ES2199947T3 (de)
NZ (1) NZ257148A (de)
PT (1) PT666919E (de)
WO (1) WO1994009142A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795768A (en) * 1991-02-12 1998-08-18 Heska Corporation Filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
US6419923B1 (en) 1991-02-12 2002-07-16 Heska Corporation Filariid nematode cysteine protease proteins, and uses thereof
JPH07505787A (ja) * 1993-02-05 1995-06-29 ダラテク・プロプライエタリー・リミテッド ファスキオラ種から取得可能なポリペプチド類，およびワクチン，処置法およびそのｄｎａ配列
GB9312324D0 (en) * 1993-06-15 1993-07-28 Pitman Moore Inc Vaccine
JPH10500854A (ja) * 1994-05-26 1998-01-27 ヘスカ コーポレイション 新規な寄生虫プロテアーゼの遺伝子およびタンパク質
GB9419969D0 (en) * 1994-10-04 1994-11-16 Mallinckrodt Veterinary Inc Vaccine
GB9612214D0 (en) * 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
NZ337697A (en) 1997-03-11 2001-06-29 Stichting Dienst Landbouwkundi An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
EP2485725A2 (de) 2009-10-07 2012-08-15 Wyeth LLC Zusammensetzungen mit adjuvanzien, makroliden und proteinösen antigenen sowie verwendungsverfahren dafür

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
WO1990008819A1 (en) * 1989-01-31 1990-08-09 Daratech Pty. Ltd. Vaccine for the preventative treatment of infection of liver fluke in ruminants
JPH07501219A (ja) * 1991-11-12 1995-02-09 ザ・コロラド・ステイト・ユニバーシティ・リサーチ・ファンデーション 心糸状虫に対するプロテアーゼワクチン
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
CA2147378A1 (en) 1994-04-28
NZ257148A (en) 1996-04-26
EP0666919B1 (de) 2003-05-14
JPH08502404A (ja) 1996-03-19
PT666919E (pt) 2003-09-30
DE69332977D1 (de) 2003-06-18
DK0666919T3 (da) 2003-09-08
EP0666919A1 (de) 1995-08-16
US20050208063A1 (en) 2005-09-22
WO1994009142A1 (en) 1994-04-28
ES2199947T3 (es) 2004-03-01
AU5340094A (en) 1994-05-09
US6623735B1 (en) 2003-09-23
DE69332977T2 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
DK0656888T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfonamider, anvendelige som retrovirale protease-inhibitorer
DE68918952D1 (de) Emulsionen von perfluorhaltigen organischen verbindungen.
DE69307738D1 (de) Retrovirale protease inhibitoren, enthaltend cyclische sulfone
ATE296625T1 (de) Retrovirusprotease inhibitoren
DK0656886T3 (da) N-(Alkanoylamino-2-hydroxypropyl)-sulfonamider til anvendelse som inhibitorer af retrovirale proteaser
ES2150933T3 (es) Inhibidores de la proteasa vih utiles para el tratamiento del sida.
ATE196466T1 (de) Inhibitoren retroviraler proteasen
DE69332977D1 (de) Thiolprotease enthaltender impfstoff
ES2067154T3 (es) Dibenzoilalquilcianohidracinas.
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE3683170D1 (de) Peptid-derivate, renin- und saeureprotease hemmende mittel.
DE69326077D1 (de) Sulfonylalkanoylaminohydroxyethylaminosulfaminsäuren verwendbar als inhibitoren retroviraler proteasen
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
EP0975353A4 (de) Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
FI884955A0 (fi) Konserverade haor- och hudrengoeringsmedel och anvaendning av en konserveringsmedelkombination.
ATE357510T1 (de) Von willebrand-faktor multimerase
ATE176402T1 (de) Serinprotease enthaltender impfstoff
BE876296A (fr) Compositions pharmaceutiques contenant des prostaglandines
ATE158304T1 (de) Dithiolanylglycinhaltige hiv-proteaseinhibitoren vom hydroxyethylenisostertyp
ES2117362T3 (es) Composicion cosmetica o farmaceutica que contiene un carbamato de alquilo como agente hidratante.
NO950897D0 (no) Inhibisjon av retro virusinfeksjon
DE69231575D1 (de) Waschmittelenzyme
PT878195E (pt) Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
ES2067140T3 (es) Compuestos fenilester de acido benzoico y composiciones inhibidoras de la elastasa que contienen los mismos.
GR1001368B (el) Φαρμακευτικοί φορείς.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0666919

Country of ref document: EP

REN Ceased due to non-payment of the annual fee